Proteomic analysis in giant axonal neuropathy: New insights into disease mechanisms

Muscle and Nerve

Volumn 46, Issue 2, 2012, Pages 246-256

  Mussche, Silke ^a   De Paepe, Boel ^a   Smet, Joél ^a   Devreese, Katrien ^a   Lissens, Willy ^b   Rasic, Vedrana Milic ^c   Murnane, Matthew ^d   Devreese, Bart ^e   Van Coster, Rudy ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d ALBANY MEDICAL CENTER   (United States)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

2D LC MS; Cytoskeletal reorganization; Fibroblasts; GAN; Giant axonal neuropathy; ITRAQ; Proteomics; Vimentin

Indexed keywords

BINDING PROTEIN; FORMIN BINDING PROTEIN; GALECTIN 1; MICROSOMAL AMINOPEPTIDASE; NUCLEAR PROTEIN; PROTEASE NEXIN I; RIBOSOMAL PROTEIN L29; RIBOSOMAL PROTEIN L37; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GIANT AXONAL NEUROPATHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; PROTEOMICS;

ANTIGENS, CD13; AXONS; FEMALE; FIBROBLASTS; GALECTIN 1; GIANT AXONAL NEUROPATHY; HUMANS; MALE; PROTEOMICS; RIBOSOMAL PROTEINS; SERPIN E2;

EID: 84863991310     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23306     Document Type: Article

References (41)

1. Berg BO, Rosenberg SH, Asbury AK. Giant axonal neuropathy. Pediatrics 1972; 49: 894-899.
2. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol 2004; 58: 131-148.
3. Prineas JW, Ouvrier RA, Wright RG, Walsh JC, Mcleod JG. Giant axonal neuropathy - generalized disorder of cytoplasmic microfilament formation. J Neuropathol Exp Neurol 1976; 35: 458-470.
4. Bomont P, Koenig M. Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Hum Mol Genet 2003; 12: 813-822.
5. Pena SDJ, Opas M, Turksen K, Kalnins VI, Carpenter S. Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy. Eur J Cell Biol 1983; 31: 227-234.
6. Bomont P, Cavalier L, Blondeau F, Hamida CB, Belal S, Tazir M, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000; 26: 370-374.
7. Koop O, Schirmacher A, Nelis E, Timmerman V, De Jonghe P, Ringelstein B, et al. Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN). Neuromuscul Disord 2007; 17: 624-630.
8. Demir E, Bomont P, Erdem S, Cavalier L, Demirci M, Kose G, et al. Giant axonal neuropathy: clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry 2005; 76: 825-832.
9. Bomont P, Ioos C, Yalcinkaya C, Korinthenberg R, Vallat JM, Assami S, et al. Identification of seven novel mutations in the GAN gene. Hum Mutat 2003; 21: 446.
10. Kuhlenbaumer G, Young P, Oberwittler C, Hunermund G, Schirmacher A, Domschke K, et al. Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene. Neurology 2002; 58: 1273-1276.
11. Bruno C, Bertini E, Federico A, Tonoli E, Lispi ML, Cassandrini D, et al. Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology 2004; 62: 13-16.
12. Houlden H, Groves M, Miedzybrodzka Z, Roper H, Willis T, Winer J, et al. New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J Neurol Neurosurg Psychiatry 2007; 78: 1267-1270.
13. Leung CL, Pang Y, Shu C, Goryunov D, Liem RK. Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients. BMC Genet 2007; 8: 6.
14. Furukawa M, He YZJ, Borchers C, Xiong Y. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat Cell Biol 2003; 5: 1001-1007.
15. Ding JQ, Liu JJ, Kowal AS, Nardine T, Bhattacharya P, Lee A, et al. Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. J Cell Biol 2002; 158: 427-433.
16. Ding JQ, Allen E, Wang W, Valle A, Wu CB, Nardine T, et al. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum Mol Genet 2006; 15: 1451-1463.
17. Wang W, Ding JQ, Allen E, Zhu P, Zhang L, Vogel H, et al. Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway. Curr Biol 2005; 15: 2050-2055.
18. Allen E, Ding JQ, Wang W, Pramanik S, Chou J, Yau V, et al. Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature 2005; 438: 224-228.
19. Cleveland DW, Yamanaka K, Bomont P. Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Hum Mol Genet 2009; 18: 1384-1394.
20. Buysse K, Vergult S, Mussche S, Ceuterick-de Groote C, Speleman F, Menten B, et al. Giant axonal neuropathy caused by compound heterozygosity for a maternally inherited microdeletion and a paternal mutation within the GAN gene. Am J Med Genet A 2010; 152: 2802-2804.
21. Reidegeld KA, Eisenacher M, Kohl M, Chamrad D, Korting G, Blueggel M, et al. An easy-to-use Decoy Database Builder software tool, implementing different decoy strategies for false discovery rate calculation in automated MS/MS protein identifications. Proteomics 2008; 8: 1129-1137.
22. Snel B, Lehmann G, Bork P, Huynen MA. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 2000; 28: 3442-3444.
23. Kortazar D, Fanarraga ML, Carranza G, Bellido J, Villegas JC, Avila J, et al. Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation. Exp Cell Res 2007; 313: 425-436.
24. Helfand BH, Mendez MG, Murthy SNP, Shumaker DK, Grin B, Mahammad S, et al. Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell 2011; 22: 1274-1289.
25. Radisky DC. Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325-4326.
26. Mandal AK, Lyden TW, Fazel A, Saklayen MG, Mehrotra B, Mehling B, et al. Heparin-induced endothelial-cell cytoskeletal reorganization - a potential mechanism for vascular relaxation. Kidney Int 1995; 48: 1508-1516.
27. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004; 23: 317-329.
28. Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 2001; 20: 7486-7493.
29. Janosch P, Kieser A, Eulitz M, Lovric J, Sauer G, Reichert M, et al. The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments. FASEB J 2000; 14: 2008-2021.
30. Lamb NJC, Fernandez A, Feramisco JR, Welch WJ. Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the camp-dependent protein-kinase. J Cell Biol 1989; 108: 2409-2422.
31. Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006; 16: 137R-157R.
32. Goode BL, Eck MJ. Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem 2007; 76: 593-627.
33. Fouillit M, Joubert-Caron R, Poirier F, Bourin P, Monostori E, Levi-Strauss M, et al. Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 2000; 10: 413-419.
34. Li ZZ, Zhang YY, Li DQ, Feng Y. Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 2000; 20: 4944-4953.
35. Lu ZF, Ku L, Chen Y, Feng Y. Developmental abnormalities of myelin basic protein expression in fyn knock-out brain reveal a role of Fyn in posttranscriptional regulation. J Biol Chem 2005; 280: 389-395.
36. Takai Y, Kitano K, Terawaki S, Maesaki R, Hakoshima T. Structural basis of the cytoplasmic tail of adhesion molecule CD43 and its binding to ERM proteins. J Mol Biol 2008; 381: 634-644.
37. Park JW, Voss PG, Grabski S, Wang JL, Patterson RJ. Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res 2001; 29: 3595-3602.
38. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci U S A 2007; 104: 17965-17970.
39. Gamp AC, Tanaka Y, Lullmann-Rauch R, Wittke D, D'Hooge R, De Deyn PP, et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet 2003; 12: 631-646.
40. Pellizzoni L, Charroux B, Rappsilber J, Mann M, Dreyfuss G. A functional interaction between the survival motor neuron complex and RNA polymerase II. J Cell Biol 2001; 152: 75-85.
41. Wilson BJ, Giguere V. Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis. BMC Genomics 2007; 8: 419.